Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor Agonists

被引:24
作者
Bolchi, Cristiano [1 ]
Valoti, Ermanno [1 ]
Gotti, Cecilia [2 ,3 ]
Fasoli, Francesca [2 ,3 ]
Ruggeri, Paola [1 ]
Fumagalli, Laura [1 ]
Binda, Matteo [1 ]
Mucchietto, Vanessa [2 ,3 ]
Sciaccaluga, Miriam [4 ]
Budriesi, Roberta [6 ]
Fucile, Sergio [4 ,5 ]
Pallavici, Marco [1 ]
机构
[1] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, I-20133 Milan, Italy
[2] CNR, Ist Neurosci, I-20129 Milan, Italy
[3] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, I-20129 Milan, Italy
[4] IRCCS Neuromed, Ist Neurol Mediterraneo, I-86077 Pozzilli, Isernia, Italy
[5] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol, I-00185 Rome, Italy
[6] Univ Bologna, Dipartimento Farm & Biotecnol, Alma Mater Studiorum, I-40126 Bologna, Italy
关键词
SAZETIDINE-A; NICOTINIC AFFINITY; SMOKING-CESSATION; POTENT; VARENICLINE; ANTIDEPRESSANT; SELECTIVITY; CYTISINE; EFFICACY; 5-(2-PYRROLIDINYL)OXAZOLIDINONES;
D O I
10.1021/acs.jmedchem.5b00904
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Some unichiral analogues of 2R,2'S-2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane, a potent and selective alpha 4 beta 2-nAChR partial agonist, were designed by opening dioxane and replacing hydroxyl carbon with nitrogen. The resulting 3-pyridyl and m-hydroxyphenyl ethers have high alpha 4 beta 2 affinity and good subtype selectivity, which get lost if OH is removed from phenyl or the position of pyridine nitrogen is changed. High alpha 4 beta 2 affinity and selectivity are also attained by meta hydroxylating the 3-pyridyl and the phenyl ethers of (S)-N-methylprolinol and the phenyl ether of (S)-2-azetidinemethanol, known alpha 4 beta 2 agonists, although the interaction mode of the aryloxymethylene substructure cannot be assimilated to that of benzodioxane. Indeed, the alpha 4 beta 2 and alpha 3 beta 4 functional tests well differentiate behaviors that the binding tests homologize: both the 3-hydroxyphenyl and the 5-hydroxy-3-pyridyl ether of N-methylprolinol are alpha 4 beta 2 full agonists, but only the latter is highly alpha 4 beta 2/alpha 3 beta 4 selective, while potent and selective partial alpha 4 beta 2 agonism characterizes the hydroxybenzodioxane derivative and its two opened semirigid analogues.
引用
收藏
页码:6665 / 6677
页数:13
相关论文
共 38 条
  • [1] Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
    Abreo, MA
    Lin, NH
    Garvey, DS
    Gunn, DE
    Hettinger, AM
    Wasicak, JT
    Pavlik, PA
    Martin, YC
    DonnellyRoberts, DL
    Anderson, DJ
    Sullivan, JP
    Williams, M
    Americ, SP
    Holladay, MW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) : 817 - 825
  • [2] Enantiomerically Pure Dibenzyl Esters of L-Aspartic and L-Glutamic Acid
    Bolchi, Cristiano
    Valoti, Ermanno
    Fumagalli, Laura
    Straniero, Valentina
    Ruggeri, Paola
    Pallavicini, Marco
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2015, 19 (07) : 878 - 883
  • [3] Unichiral 2-(2′-Pyrrolidinyl)-1,4-benzodioxanes: the 2R,2′S Diastereomer of the N-Methyl-7-hydroxy Analogue Is a Potent α4β2-and α6β2-Nicotinic Acetylcholine Receptor Partial Agonist
    Bolchi, Cristiano
    Gotti, Cecilia
    Binda, Matteo
    Fumagalli, Laura
    Pucci, Luca
    Pistillo, Francesco
    Vistoli, Giulio
    Valoti, Ermanno
    Pallavicini, Marco
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (21) : 7588 - 7601
  • [4] Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-Bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors
    Bunnelle, William H.
    Daanen, Jerome F.
    Ryther, Keith B.
    Schrimpf, Michael R.
    Dart, Michael J.
    Gelain, Arianna
    Meyer, Michael D.
    Frost, Jennifer M.
    Anderson, David J.
    Buckley, Michael
    Curzon, Peter
    Cao, Ying-Jun
    Puttfarcken, Pamela
    Searle, Xenia
    Ji, Jianguo
    Putman, C. Brent
    Surowy, Carol
    Toma, Lucio
    Barlocco, Daniela
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (15) : 3627 - 3644
  • [5] Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380
    Caldarone, Barbara J.
    Wang, Daguang
    Paterson, Neil E.
    Manzano, Michael
    Fedolak, Allison
    Cavino, Katie
    Kwan, Mei
    Hanania, Taleen
    Chellappan, Sheela K.
    Kozikowski, Alan P.
    Olivier, Berend
    Picciotto, Marina R.
    Ghavami, Afshin
    [J]. PSYCHOPHARMACOLOGY, 2011, 217 (02) : 199 - 210
  • [6] (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine Maleate (SIB-1508Y): A novel anti-Parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors
    Cosford, NDP
    Bleicher, L
    Herbaut, A
    McCallum, JS
    Vernier, JM
    Dawson, H
    Whitten, JP
    Adams, P
    ChavezNoriega, L
    Correa, LD
    Crona, JH
    Mahaffy, LS
    Menzaghi, F
    Rao, TS
    Reid, R
    Sacaan, AI
    Santori, E
    Stauderman, KA
    Whelan, K
    Lloyd, GK
    McDonald, IA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (17) : 3235 - 3237
  • [7] Novel 2-(2'-furo[3,2-b]pyridinyl) pyrrolidines: Potent neuronal nicotinic acetylcholine receptor ligands
    Elliott, RL
    Ryther, KB
    Anderson, DJ
    PiattoniKaplan, M
    Kuntzweiler, TA
    DonnellyRoberts, D
    Arneric, SP
    Holladay, MW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (21) : 2703 - 2708
  • [8] 2-(aryloxymethyl)azacyclic analogues as novel nicotinic acetylcholine receptor (nAChR) ligands
    Elliott, RL
    Kopecka, H
    Gunn, DE
    Lin, NH
    Garvey, DS
    Ryther, KB
    Holladay, MW
    Anderson, DJ
    Campbell, JE
    Sullivan, JP
    Buckley, MJ
    Gunther, KL
    ONeill, AB
    Decker, MW
    Arneric, SP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (19) : 2283 - 2288
  • [9] Cytisine for smoking cessation - A literature review and a meta-analysis
    Etter, Jean-Francois
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (15) : 1553 - 1559
  • [10] Frölich L, 2011, J ALZHEIMERS DIS, V24, P363, DOI [10.3233/JAD-2010-101554, 10.3233/JAD-2011-101554]